Abstract:
The present invention relates to a chemical compound of formula (I) as a neutral or acidic salt thereof where the counter ions are Li , Na , K , Mg , Ca , NH4 or another pharmacologically acceptable positively charged inorganic or organic ion or any combination thereof and a pharmaceutical composition comprising as a pharmaceutically active ingredient at least one compound of formula (I).
Abstract:
The present invention relates to derivatives of phosphorylated carbohydrates and pharmaceutical compositions comprising as a pharmaceutically active ingredient at least one of these compounds.
Abstract:
A VOC free cross linking product for waterborn coatings is described. The crosslinking product comprises at least one cross linking agent and at least one viscosity reducing compound.
Abstract:
The present invention relates to a hydroxy- sulphureous acid, to a method for preparation of the hydroxysulphureous acid and to products based on said hydroxysulphureous acid, to methods for preparation of said products and to use of said products, wherein said hydroxysulphureous acid is used as building blocks for polymer systems, e g aqueous polymer systems such as inks, coatings, and adhesives.
Abstract:
The present invention relates to a method for coating a floor, wherein said method comprises applying an aqueous dispersion comprising polyurethane, an acrylate or a hybride or mixture thereof; drying said coating and subjecting the physically dry coating to ultraviolet radiation whereby a cured coating is obtained. The claimed invention also relates to reactive additives suitable for use in the methods as well as the floor itself.
Abstract:
A heterocyclic chemical compound of formula (1) or (2) or a neutral or acidic salt thereof where the counter ion is LI , Na , K , Mg , Ca , NH4 or another pharmacologically acceptable positively charged inorganic or organic ion or any combination thereof. The compound contains B, Si, N, P, S or Se in the ring structure.
Abstract:
The invention relates to an inositol phosphate containing pharmaceutical composition which comprises an aliphatic ester or ether for improvement of the bioavailability of the inositol phosphate in mammals including man at non-parenteral administration. The invention also covers the use of at least one aliphatic ester or ether compound for the preparing of an inositol phosphate containing medicament with improved bioavailability of inositol phosphate in mammals including man at non-parenteral administration.
Abstract:
The use of an ester of inositoltrisphosphate for the preparing of a medicament for preventing, alleviating or combatting inflammatory conditions in mammals including man.